CHEBI:31646 - Gefarnate

ChEBI IDCHEBI:31646
ChEBI NameGefarnate
Stars
Last Modified22 February 2017
DownloadsMolfile
FormulaC27H44O2
Net Charge0
Average Mass400.647
Monoisotopic Mass400.33413
SMILESCC(C)=CCC/C(C)=C/CC/C(C)=C/CCC(=O)OC/C=C(\C)CCC=C(C)C
InChIInChI=1S/C27H44O2/c1-22(2)12-8-14-24(5)16-10-17-25(6)18-11-19-27(28)29-21-20-26(7)15-9-13-23(3)4/h12-13,16,18,20H,8-11,14-15,17,19,21H2,1-7H3/b24-16+,25-18+,26-20+
InChIKeyZPACYDRSPFRDHO-ROBAGEODSA-N
Roles Classification
Applications:
cardiovascular drug  A drug that affects the rate or intensity of cardiac contraction, blood vessel diameter or blood volume.
anti-ulcer drug  One of various classes of drugs with different action mechanisms used to treat or ameliorate peptic ulcer or irritation of the gastrointestinal tract.
ChEBI Ontology
Outgoing Relation(s)
Gefarnate (CHEBI:31646) has role anti-ulcer drug (CHEBI:49201)
Gefarnate (CHEBI:31646) has role cardiovascular drug (CHEBI:35554)
Gefarnate (CHEBI:31646) is a organic molecular entity (CHEBI:50860)
INN  Source
gefarnatoWHO MedNet
Synonyms  Source
DA 688ChEMBL
DA-688ChEMBL
dixnalateDrugCentral
GefanilChEMBL
GefarnateKEGG COMPOUND
gefarnylDrugCentral
Manual XrefsDatabases
1281DrugCentral
D01529KEGG DRUG
Registry NumbersSources
CAS:51-77-4KEGG COMPOUND
Citations